Home > Insider Trading > Filing (0001358403-16-000294)

Filing Details

Accession Number:: 0001358403-16-000294
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-29 16:05:10
Reporting Period:: 2016-11-25

Filing Date:: 2016-11-29
Accepted Time:: 2016-11-29 16:05:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358403	Bellicum Pharmaceuticals Inc	BLCM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295830	A Alan Musso	C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030	Cfo And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2016-11-25	6,273	$20.48	83,575	No	4	S	Direct
Common Stock	Disposition	2016-11-28	22,427	$19.23	61,148	No	4	S	Direct
Common Stock	Disposition	2016-11-28	600	$19.85	60,548	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on December 22, 2015.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.23 to $20.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Includes 665 shares acquired under the Issuer's Employee Stock Purchase Plan, the "ESPP" on June 10, 2016; and 441 shares acquired under the ESPP on December 10, 2015.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.71 to $19.6826. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.72 to $20.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.